Author details

Full Name

Dominique J Verlaan

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
22271045	Interaction between genetic and epigenetic variation defines gene expression patterns at the asthma-associated locus 17q12-q21 in lymphoblastoid cell lines.	Hum Genet	2012
22504420	Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.	Nat Genet	2012
22534532	Promoter polymorphisms in CHI3L1 are associated with asthma.	J Allergy Clin Immunol	2012
21418647	Genome-wide assessment of imprinted expression in human cells.	Genome Biol	2011
20881960	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	Nature	2010
19760287	Inherited cavernous malformations of the central nervous system: clinical and genetic features in 19 Swiss families.	Neurosurg Rev	2010
18971308	Targeted screening of cis-regulatory variation in human haplotypes.	Genome Research	2009
19732864	Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease.	Am J Hum Genet	2009
19605794	A probabilistic approach for SNP discovery in high-throughput human resequencing data.	Genome Research	2009
19105188	The proportion of mutations predicted to have a deleterious effect differs between gain and loss of function genes in neurodegenerative disease.	Hum Mutat	2009
19654370	Population genomics in a disease targeted primary cell model.	Genome Res	2009
19794070	A cis-acting regulatory variant in the IL2RA locus.	J Immunol	2009
19838192	Global patterns of cis variation in human cells revealed by high-density allelic expression analysis.	Nat Genet	2009
18455228	Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study.	Lancet	2008
19001169	A novel duplication confirms the involvement of 5q23.2 in autosomal dominant leukodystrophy.	Arch Neurol	2008
18241056	A novel locus for idiopathic generalized epilepsy in French-Canadian families maps to 10p11.	Am J Med Genet A	2008
17211633	Large germline deletions and duplication in isolated cerebral cavernous malformation patients.	Neurogenetics	2007
16740915	A new locus for autosomal dominant intracranial aneurysm, ANIB4, maps to chromosome 5p15.2-14.3.	J Med Genet	2006
16380626	CCM3 mutations are uncommon in cerebral cavernous malformations.	Neurology	2005
15702360	[Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families].	Nervenarzt	2005
15079030	CCM1 mutation screen of sporadic cases with cerebral cavernous malformations.	Neurology	2004
15557534	No CCM2 mutations in a cohort of 31 sporadic cases.	Neurology	2004
15455397	A mutation in the HSN2 gene causes sensory neuropathy type II in a Lebanese family.	Ann Neurol	2004
15174026	The 14q restless legs syndrome locus in the French Canadian population.	Ann Neurol	2004
15122722	CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations.	Ann Neurol	2004
14624391	Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.	Am J Hum Genet	2003
12774951	Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation.	Can J Neurol Sci	2003
11914398	Cerebral cavernous malformations: mutations in Krit1.	Neurology	2002
11941540	Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation.	Am J Hum Genet	2002